NET1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.026040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.949800E-01
Normal-vs-Stage2
7.573600E-02
Normal-vs-Stage3
3.410800E-01
Normal-vs-Stage4
9.270400E-02
Stage1-vs-Stage2
6.716400E-01
Stage1-vs-Stage3
7.296600E-01
Stage1-vs-Stage4
2.208600E-01
Stage2-vs-Stage3
3.873200E-01
Stage2-vs-Stage4
4.795600E-02
Stage3-vs-Stage4
1.691790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.055350E-01
Normal-vs-AfricanAmerican
2.162200E-01
Normal-vs-Asian
1.403240E-01
Caucasian-vs-AfricanAmerican
5.949400E-01
Caucasian-vs-Asian
4.230600E-01
AfricanAmerican-vs-Asian
9.474000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.447600E-02
Normal-vs-Female
1.554600E-01
Male-vs-Female
2.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.915000E-01
Normal-vs-Age(41-60Yrs)
8.957800E-02
Normal-vs-Age(61-80Yrs)
1.199040E-01
Normal-vs-Age(81-100Yrs)
7.217800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.967200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.534200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.346800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.597010E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.579000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.510400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.083420E-01
Normal-vs-Daily Drinker
1.395180E-01
Normal-vs-Weekly Drinker
2.180600E-01
Normal-vs-Occasional Drinker
5.688400E-02
Normal-vs-Social Drinker
7.357900E-02
Non Drinker-vs-Daily Drinker
4.670200E-01
Non Drinker-vs-Weekly Drinker
4.079400E-01
Non Drinker-vs-Occasional Drinker
2.611400E-01
Non Drinker-vs-Social Drinker
4.298000E-02
Daily Drinker-vs-Weekly Drinker
2.260800E-01
Daily Drinker-vs-Occasional Drinker
7.730400E-01
Daily Drinker-vs-Social Drinker
3.296000E-02
Weekly Drinker-vs-Occasional Drinker
1.004800E-01
Weekly Drinker-vs-Social Drinker
4.957200E-01
Occasional Drinker-vs-Social Drinker
9.236900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.459790E-01
Normal-vs-Grade 2
2.479600E-02
Normal-vs-Grade 3
2.187800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.317900E-03
Grade 1-vs-Grade 3
5.754300E-04
Grade 1-vs-Grade 4
1.459790E-01
Grade 2-vs-Grade 3
1.644220E-01
Grade 2-vs-Grade 4
2.479600E-02
Grade 3-vs-Grade 4
2.187800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.314560E-01
Normal-vs-NonDiabetic
1.006800E-01
Diabetic-vs-NonDiabetic
9.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.946000E-02
Normal-vs-NoPancreatitis
1.144570E-01
Pancreatitis-vs-NoPancreatitis
2.385000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.383020E-01
Normal-vs-N1
8.083600E-02
N0-vs-N1
3.568000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.526340E-02
Normal-vs-TP53-NonMutant
4.444200E-01
TP53-Mutant-vs-TP53-NonMutant
3.71570552104572E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
